References
Arosio E, Pancera P, Zannoni M, Arcaro G, Priante F, et al. Defibrotide and peripheral obliterative arterial disease: preliminary data. International Journal of Clinical Pharmacology Therapy and Toxicology 27: 526–529, 1989
Avellone G, Di Garbo V, Cordova RM, Nazzari M, Bompiani G. Hemorheologic and antithrombotic effects of defibrotide in patients with claudicatio intermittens. Thrombotic and Haemorrhagic Disorders 7: 35–40, 1993
Belfiglio A, Traietti P, Bologna E, Salvo G. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease. Clinical Therapeutics 11: 479–484, 1989
Boissel JP, Sacks HS, Leizorovicz A, Blanchard J, Panak E, et al. Meta-analysis of clinical trials: summary of an international conference. European Journal of Clinical Pharmacology 34: 535–538, 1988
Cameron HA, Waller PC, Ramsay LE. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965–1985. British Journal of Clinical Pharmacology 26: 569–576, 1988
Cappelli R, Pecchi S, Pieragalli D. et al. Effect on rheological and some peripheral haemodynamic parameters of defibrotide in POAD patients. Clinical Hemorheology 7: 247–252, 1987
Coccheri S, Biagi G. Defibrotide. Cardiovascular Drug Reviews 9: 172–196, 1991
Cochran WG. The combination of estimates from different experiments. Biometrics 10: 101–129, 1954
Colditz GA, Halvorsen KT, Goldhaber SZ. Randomised clinical trials of transdermal nitroglycerin systems for the treatment of angina: a meta analysis. American Heart Journal 116: 174–180, 1988
Craveri A, Tomaghi G, Ranieri R, Stanzani M, Landi G, et al. Effects of defibrotide after oral and parenteral administration in patients with peripheral arterial disease (PAD). International Angiology 9: 274–277, 1990
De Luca N, Crispino MR, Marcheggiani R, et al. Terapia delle arteriopatie periferiche di tipo aterosclerotico con defibrotide somministrato per os: studio controllato in doppio cieco versus placebo. Medical Praxis 8: 1–8, 1987
Di Perri T, Laghi Pasini F, Acciavatti A, et al. Haemodynamics rheology and mechanism of action of iloprost in man. Clinical Hemorheology 10: 171–183, 1990
Lindgaerde F, Jelnes R, Adielsson G, et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation 80: 1549–1556, 1989
Marelli C, Belcaro G, Girardello R. Defibrotide in patients with intermittent claudication. Improvement in blood flow, fibrinolytic activity and microcirculation after six months of treatment. Current Therapeutic Research 47: 459–465, 1990
Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C. Effects of defibrotide on physical performance and hemorheology picture in patients with peripheral arteriopathy. Clinical Trials and Meta-Analysis, in press, 1994
Palmer KJ, Goa KL. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs 45: 259–294, 1993
Romeo S, Viola S, Bonaccorsi R, Iapichino G, Carullo F. II defibrotide nelle arteriopatie periferiche ostruttive. Studio policentrico. Medical Praxis 10: 141–149, 1989
Sabba’ C, Zupo V, Dina F, Nazzari M, Albano O. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease. International Journal of Clinical Pharmacology Therapy and Toxicology 26: 249–252, 1988
Strano A, Fareed J, Sabba’ C, et al. A double blind, multicenter, placebo controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease. Seminars in Thrombosis and Hemostasis 17(Suppl. 2): 228–234, 1991
Ulutin ON. Clinical effectiveness of defibrotide in vasoocclusive disorders and its mode of actions. Seminars in Thrombosis and Hemostasis 14 (Suppl.): 58–63, 1988
Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. Journal of Clinical Epidemiology 45: 529–542, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferrari, P., Clerici, G., Gussoni, G. et al. Defibrotide versus Placebo in the Treatment of Intermittent Claudication. Drug Invest 7, 157–160 (1994). https://doi.org/10.1007/BF03258468
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03258468